Basic Information | Post buying leads | Suppliers |
Name |
Marbofloxacin |
EINECS | 640-416-5 |
CAS No. | 115550-35-1 | Density | 1.55 g/cm3 |
PSA | 78.25000 | LogP | 0.57620 |
Solubility | Soluble in DMSO at 2mg/ml. Soluble in water or ethanol at <1mg/ml | Melting Point |
268-269 ºC |
Formula | C17H19FN4O4 | Boiling Point | 570.5 ºC at 760 mmHg |
Molecular Weight | 362.36 | Flash Point | 298.8 ºC |
Transport Information | N/A | Appearance | yellow or primrose yellow powder |
Safety | 61-36-26 | Risk Codes | 52/53-36/37/38 |
Molecular Structure | Hazard Symbols | Xi | |
Synonyms |
Marbocyl;Marbofloxacine;9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(3,2,1-ij)(4,1,2)benzoxadiazine-6-carboxylic acid;Marbofloxacin [INN];CCRIS 8212;Marbofloxacine [INN-French];Marbofloxacino;Marbofloxacinum;7H-Pyrido(3,2,1-ij)(4,1,2)benzoxadiazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-; |
Product Name: Marbofloxacin
Synonyms of Marbofloxacin (CAS NO.115550-35-1): Marbofloxacin [INN] ; 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(3,2,1-ij)(4,1,2)benzoxadiazine-6-carboxylic acid ; CCRIS 8212 ; Marbofloxacine ; Marbofloxacine [INN-French] ; Marbofloxacino ; Marbofloxacino [INN-Spanish] ; Marbofloxacinum ; Marbofloxacinum [INN-Latin] ; UNII-8X09WU898T ; 7H-Pyrido(3,2,1-ij)(4,1,2)benzoxadiazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-
CAS NO: 115550-35-1
Classification Code: Drug / Therapeutic Agent ; Enzyme inhibitors
Molecular Formula: C17H19FN4O4
Molecular Weight: 362.3556
Molecular Structure:
Melting Point: 268-269°C
Polar Surface Area: 65.56 Å2
Index of Refraction: 1.701
Molar Refractivity: 90.37 cm3
Molar Volume: 233.5 cm3
Surface Tension: 78.3 dyne/cm
Density: 1.55 g/cm3
Flash Point: 298.8 °C
Enthalpy of Vaporization: 90.02 kJ/mol
Boiling Point: 570.5 °C at 760 mmHg
Vapour Pressure: 7.45E-14 mmHg at 25°C
Marbofloxacin (CAS NO.115550-35-1) is used in veterinary medicine under the trade names Marbocyl and Zeniquin. It can be used both orally and topically. Marbofloxacin (CAS NO.115550-35-1) is particularly used for infections of the skin, respiratory system and mammary glands, as well as with urinary tract infections in dogs.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | oral | > 2gm/kg (2000mg/kg) | United States Patent Document. Vol. #4801584, |
Hazard Codes: Xi
Risk Statements: 52/53-36/37/38
R52/53: Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
R36/37/38: Irritating to eyes, respiratory system and skin.
Safety Statements: 61-36-26
S61: Avoid release to the environment. Refer to special instructions / safety data sheets.
S36: Wear suitable protective clothing.
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
RTECS: UU8815140
Mechanism of action: Marbofloxacin (CAS NO.115550-35-1) is a quinolone, and acts by inhibiting bacterial DNA replication.